医学
坎德萨坦
氯沙利酮
氢氯噻嗪
血压
内科学
阿替洛尔
氨氯地平
钙通道阻滞剂
噻嗪
心脏病学
利尿剂
内分泌学
血管紧张素II
作者
Robert M. Carey,Andrew E. Moran,Paul K. Whelton
出处
期刊:JAMA
[American Medical Association]
日期:2022-11-08
卷期号:328 (18): 1849-1849
被引量:381
标识
DOI:10.1001/jama.2022.19590
摘要
Hypertension affects approximately 116 million adults in the US and more than 1 billion adults worldwide and is a leading cause of CVD morbidity and mortality. First-line therapy for hypertension is lifestyle modification, consisting of weight loss, dietary sodium reduction and potassium supplementation, healthy dietary pattern, physical activity, and limited alcohol consumption. When drug therapy is required, first-line therapies are thiazide or thiazidelike diuretics, angiotensin-converting enzyme inhibitor or angiotensin receptor blockers, and calcium channel blockers.
科研通智能强力驱动
Strongly Powered by AbleSci AI